Pfiz­er CEO to haul in al­most $50M in com­pen­sa­tion in 2021 and 2022

Pfiz­er’s mul­ti-bil­lion-dol­lar, life­sav­ing Covid-19 vac­cine will like­ly hold on­to the record for most med­ical prod­uct sales for a long time com­ing. And those new­found bil­lions mean plen­ty of things to cel­e­brate for CEO Al­bert Bourla, who may end up tak­ing home al­most $50 mil­lion in com­pen­sa­tion in 2021 and 2022.

Ac­cord­ing to an SEC fil­ing Fri­day, Bourla is set to col­lect $24.3 mil­lion in com­pen­sa­tion for his work lead­ing the Big Phar­ma be­he­moth last year, and an­oth­er $24.7 mil­lion in 2022 (pend­ing the com­pa­ny stock price, among oth­er fac­tors) — on top of the more than $21 mil­lion he made in 2020.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER